Ophthalmology Kits AYOXXA already offers detection kits for ophthalmology; target eye research institutes and CROs to drive adoption of multiplex proteomics for ocular biomarker discovery, leveraging the platform’s sensitivity to work with limited sample volumes.

Immuno Oncology Focus LUNARIS supports immuno-oncology research with multiple kits for T cell profiling and related markers, presenting opportunities to partner with IO drug developers and CROs for biomarker panels and translational readouts.

Integrated Platform Promote LUNARIS as an end-to-end solution combining multiplex analysis, image-based quality control, and data processing, appealing to pharma R&D teams seeking a streamlined translational proteomics workflow and potential licensing partnerships.

Strategic Partnerships Leverage historical collaboration activity to pursue joint ventures or distribution agreements with CROs, academic labs, and early-stage biotech startups to scale kit adoption, service capabilities, and regional reach.

Market Expansion Position the modular, EU-based platform for expansion into additional geographic markets such as the US through distributors and regional partners, aligning with clinical and translational proteomics needs in ophthalmology and IO.